| Identification | |
| Name: | WARFARIN SODIUM |
| Synonyms: | 3-(A-ACETONYLBENZYL)-4-HYDROXYCOUMARIN SODIUM;3-(ALPHA-ACETONYLBENZYL)-4-HYDROXYCOUMARIN;3-(ALPHA-ACETONYLBENZYL)-4-HYDROXYCOUMARIN SODIUM;SODIUM 4-OXO-3-(3-OXO-1-PHENYL-BUTYL)-CHROMEN-2-OLATE;WARFARIN, SODIUM CLATHRATE;WARFARIN SODIUM SALT;WARFARIN SODIUM SALT CLATHRATE |
| CAS: | 51821-81-9 |
| EINECS: | 204-929-4 |
| Molecular Formula: | C19H15NaO4 |
| Molecular Weight: | 330.31 |
| InChI: | InChI=1S/C19H16O4.Na/c1-12(20)11-15(13-7-3-2-4-8-13)17-18(21)14-9-5-6-10-16(14)23-19(17)22;/h2-10,15,21H,11H2,1H3;/q;+1/p-1 |
| Molecular Structure: |  |
| Properties | |
| Transport: | UN 1544 6.1/PG 2 |
| Specification: | Safety Statements:53-36/37/39-45 53:Avoid exposure - obtain special instruction before use 36/37/39:Wear suitable protective clothing, gloves and eye/face protection 45:In case of accident or if you feel unwell, seek medical advice immediately (show label where possible) |
| Safety Data | |
 |
|
